Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.42, $0.02 better than the analyst estimate of $2.40. Revenue for the quarter came in at $2.24 billion versus the consensus estimate of $2.22 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.30-$8.45, versus the consensus of $8.47.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
• JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight